Search

everythinglearnresearchcommunity

for

Search:↓

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

NF-κB levels can help diagnose and assess the severity of androgenetic alopecia.

Bicalutamide does not significantly affect liver enzymes and is a safe anti-androgen option for transfeminine individuals.

New method measures skin cell turnover quickly and effectively, showing turnover slows with age and responds more to treatments in older skin.

Menthol boosts the hair growth effects of Phyllanthus niruri gel.

Iontophoresis with a growth factor cocktail helps hair growth in patients with androgenetic alopecia.

Segmental Vitiligo is a stable, early-onset form of vitiligo that responds well to early treatment and is ideal for repigmentation studies.

All four treatments for early rheumatoid arthritis had similar safety profiles.

A small group of slow-growing cells causes basal cell carcinoma to return after treatment.

3α-AdiolG is a good marker for androgen activity in women with excessive hair growth and decreases with anti-androgen treatment.

Testosterone increases 3α-androstanediol levels, which can be blocked by finasteride.

3α-androstanediol helps reduce age-related cognitive and mood declines in male rats, unlike testosterone.

3α, 17β-androstanediol-glucuronide is not a useful marker for androgen excess but may help monitor certain treatments.

A new compound with strong antiandrogenic effects was found, potentially useful for treating conditions like acne and prostate cancer.

Androstanediol glucuronide is a reliable marker for hirsutism in women.

The more lipophilic the progesterone derivative, the better it binds to androgen receptors and has antiandrogenic effects.

Trienones are more effective at inhibiting the enzyme linked to hair loss than dienones.

Higher levels of a specific hormone are linked to more chest hair and acne in men.

Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.

New chemical compounds were made that effectively block an enzyme linked to prostate growth.

Some synthesized compounds were more effective than Finasteride in reducing prostate cancer cell growth and androgen levels.

CB-03-04 shows promise as a treatment for prostate issues due to its strong anti-androgen effects.

Androstenedione, a hormone supplement, doesn't improve muscle or performance and can cause harmful side effects.

Certain derivatives are more effective 5α-reductase type 2 inhibitors than finasteride.

New A-homo-B, 19-dinor steroids showed strong antiandrogenic activity without affecting the enzyme 5α-reductase or androgen receptor binding.

Measuring androstanediol glucuronide in blood is useful for assessing and tracking treatment in women with excessive hair growth.

A new method was developed to make a compound used in finasteride and epristeride with a 69% yield.

Women with acne have lower levels of a specific hormone marker than women without acne.